Efficacy and safety of 8-week regimens for the treatment of rifampicin-susceptible pulmonary tuberculosis (TRUNCATE-TB): a prespecified exploratory analysis of a multi-arm, multi-stage, open-label, randomised controlled trial

20256 citationsJournal Articlehybrid Open Access

Authors

Nicholas I. Paton

C S G Cousins · National University of Singapore

Intan P Sari · National University Hospital

Erlina Burhan

N. V. H ́ng · National University of Singapore

Victoria B. Dalay

Celina Suresh · National University of Singapore

Tutik Kusmiati · Universitas Dr. Soetomo

Abstract

Singapore National Medical Research Council; UK Department of Health and Social Care; UK Foreign, Commonwealth, and Development Office; UK Medical Research Council; Wellcome Trust; and UK Research and Innovation Medical Research Council.

Topics & Keywords

Tuberculosis Research and Epidemiology Pneumonia and Respiratory Infections Epilepsy research and treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Lancet Infectious Diseases

Volume 25, Issue 10, pp. 1084-1096

DOI: 10.1016/s1473-3099(25)00151-3

Field-Weighted Citation Impact: 8.54